New PNH drug trial aims to boost red blood cells in patients with persistent anemia
Disease control
Ongoing
This early-stage study tests a new drug called VSA012 in about 50 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. The goal is to see if the drug is safe and can improve red blood cell levels in patients who still have anemia despite current treatment…
Phase: PHASE1 • Sponsor: Bisirna Therapeutics Pte. Ltd. • Aim: Disease control
Last updated May 09, 2026 05:34 UTC